Communiqués Clarivate Plc

Actions

CLVT

JE00BJJN4441

Marché Fermé - Nyse Autres places de cotation 22:00:02 10/06/2024			Varia. 5j.	Varia. 1 janv.
5,68 ^USD	-0,18 %		-1,90 %	-38,66 %

05/06	Transcript : Clarivate Plc Presents at Stifel 2024 Cross Sector Insight Conference, Jun-05-2024 03:35 PM
04/06	Transcript : Clarivate Plc Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 02:00 PM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Clarivate : William Blair Growth Stock Conference 2024	04/06	PU
Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas	04/06	AQ
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health Attributes from HealthWise Data	03/06	AQ
Clarivate Announces Conversion Date and Conversion Rate for Series A Mandatory Convertible Preferred Shares	31/05	AQ
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data	31/05	AQ
Clarivate Celebrates 500 Institutions Adopting Rialto Marketplace Solution	30/05	AQ
Clarivate to Present at Upcoming Investor Conferences in June 2024	29/05	PR
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024	22/05	AQ
New Clarivate Report Indicates Solid Growth in 2024 Global Trademark Filing Activity	21/05	AQ
Clarivate Launches AI-Enhanced Solution to Accelerate Trademark Watching	20/05	AQ
New Clarivate Report Reveals that the U.S., Germany and Mainland China have the most Non-Practicing Entity Litigation	16/05	AQ
OMRON Selects IPfolio from Clarivate	09/05	AQ
Clarivate : Q1 2024 – Supplemental Materials	08/05	PU
Clarivate : Corporate Governance Guidelines	08/05	PU
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis	07/05	AQ
Clarivate : Audit Committee Charter	07/05	PU
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success	02/05	AQ
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report	30/04	AQ
Clarivate joins United Nations SDG Publishers Compact	24/04	AQ
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets	23/04	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Clarivate Plc

Actions

CLVT

JE00BJJN4441

Communiqués

Filtres